1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs (Omnibus/Parent Funding Opportunity Announcements) is sponsored by National Institutes of Health (NIH) and Centers for Disease Control and Prevention (CDC). The NIH and CDC SBIR/STTR programs are one of the largest sources of early-stage capital for technology commercialization in the United States, enabling US-owned and operated small businesses to conduct research and development that has a strong potential for commercialization i…
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
U.S. Department of Health and Human Services National Institutes of Health Learn if your company is eligible for NIH SBIR or STTR funding, how to apply , and what to expect during each step of the application process. Multiple registrations are required to prepare your application and apply for funding.
Small Business Program Basics Understanding SBIR and STTR Foreign Disclosure and Risk Management SBIR and STTR Grants (NOFO s ) SBIR Contract Solicitations Commercialization Readiness Pilot (CRP) Small Business Transition Grant for New Entrepreneurs Navigate NIH's Research Areas Applicant Assistance Programs --> Transition Award (Coming Soon) Our team can help you maximize the benefits from NIH programs and resources which help you bring your innovations to life.
NIH's Technical and Business Assistance (TABA) Concept to Clinic Commercializing Innovation (C3i) The NIH is actively turning discovery into health by helping small businesses develop innovative technologies that improve health and save lives. See how .
Small Business Portfolio Overview Active Small Business Awards Research Evaluation and Commercialization Hubs (REACH) Search Technologies from Academic Centers and Hubs Our team can help you maximize the benefits from NIH programs and resources which help you bring your innovations to life. We value biomedical innovation and strive to empower scientists and entrepreneurs to bring their discoveries to patients.
HHS Small Business Program Managers Non-dilutive funding for early-stage research and development. [ Parent Announcements ] [ Specific Opportunities ] More information on HHS SBIR contracts is available on the NIH SBIR contracts webpage . NIH has committed $20 million to support academic product development and innovation.
Learn more about the five new Research Evaluation and Commercialization Hubs (REACH) in the funding opportunity announcement (RFA-OD-23-005) Standard Application Due Dates are September 5, January 5, and April 5. Due dates that fall on weekends or Federal holidays are moved to the next business day.
NIH Small Business Innovation Research (SBIR) Phase IIB Strategic Breakthrough Award (Parent [R44] Clinical Trial Optional) NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional) NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional) SBIR/STTR Commercialization Readiness Pilot (CRP) Program (Parent SB1 Clinical Trial Optional) Some SBIR/STTR grant solicitations are focused on specific research areas.
Some specific NOFOs, identified as RFAs (Requests for Applications) or PASs (Program Announcements with Set-aside funds), have funding set-aside in the Institute/Center's budget for that targeted program. National Institutes of Health Product Development Support Looking for the NIH SBIR & STTR site? The new seed.
nih. gov has everything you’re looking for about the NIH small business research and development programs (SBIR & STTR) . In addition, you can learn about other types of product development and commercialization support for NIH award recipients .
Questions? Check out About the NIH SEED Office or email us at [email protected] .
According to the current listing, eligibility includes: Eligible United States small business concerns (SBCs). NIH and CDC encourage participation by socially and economically disadvantaged small businesses and women-owned small businesses. Confirm the full requirements in the official notice before applying.
The current listing shows phase I up to $323,090; Phase II up to $2,153,927 (SBA guideline; some ICs higher). Verify award ceilings, matching requirements, and allowable costs in the official notice.
Applications for Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs (Omnibus/Parent Funding Opportunity Announcements) are due January 5, 2027. Build your timeline backwards from this date to cover registrations, approvals, and final submission checks.
Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs (Omnibus/Parent Funding Opportunity Announcements) is funded by National Institutes of Health (NIH) and Centers for Disease Control and Prevention (CDC). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
PHS 2023 Omnibus Solicitation of the NIH and CDC for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Optional) is sponsored by National Institutes of Health (NIH) and Centers for Disease Control and Prevention (CDC). This omnibus solicitation encourages small businesses to collaborate with non-profit research institutions on research and development projects related to the mission of NIH and CDC.
NIH and CDC Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Required) is sponsored by National Institutes of Health (NIH) and Centers for Disease Control and Prevention (CDC). This program supports U.S. small businesses in developing innovative health-related technologies through phased research and development, including clinical trials. It aims to advance projects aligned with NIH and CDC missions, encouraging collaborative, high-impact solutions with commercialization potential.
PA-27-034, PA-27-035 and PA-27-036 replace the institute-specific R25 announcements that research education programs have been built around for a decade. NCI, NIDA and NIGMS have already expired theirs early. Here is what the consolidation actually changes: an 8% indirect cost ceiling, a US-citizens-and-permanent-residents participant rule, a cooperative agreement variant that only exists on one of the three, and no clinical-trial-allowed companion anywhere.
Read articleNOT-OD-26-098 consolidates NIH career development awards into four parent NOFOs (KR1, KC1, KS1, KT1), eliminates the Data Management and Sharing Plan for K applications, and stops supporting K awards that let the awardee lead their own clinical trial. The RFI closes September 30, 2026; the new structure hits due dates on or after October 12, 2027.
Read articleThe Health and Extreme Weather highlighted topic went live September 1, 2026 with eleven awarding institutes and expires May 1, 2028. There is no set-aside, no separate deadline, and no review criteria — which makes the institute-by-institute language the only real signal, and it is not uniform.
Read article